Maria Trypaki

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki et al. · British Journal of Cancer · 2008 · 207 citations · Full text

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

Ioannis Boukovinas, Chara Papadaki, Pedro Méndez et al. · PLoS ONE · 2008 · 124 citations · Full text

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

Zacharenia Saridaki, Maria Tzardi, Chara Papadaki et al. · PLoS ONE · 2011 · 124 citations · Full text

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki et al. · Lung Cancer · 2009 · 88 citations

Medicine, Pathology, K-ras Mutation Status +7

Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

Galatea Kallergi, Eleni‐Kyriaki Vetsika, Despoina Aggouraki et al. · Therapeutic Advances in Medical Oncology · 2018 · 71 citations · Full text